Manufacture of pharmaceutical preparations
CURIDA HOLDING AS
Revenue 2024
NOK 13.8m
Operating profit
NOK −1.5m
Equity
NOK 196.1m
Incorporated
2015
Share capital
NOK 11.2m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 13.8m | |
| Total operating costs | 15.3m | |
| Operating profit (EBIT) | −1.5m | |
| Net financial items | 19.3m | |
| Profit for the year | 13.7m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 244.8m | |
| of which current assets | 129.6m | |
| Equity | 196.1m | |
| Total liabilities | 48.7m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.